Who
In numbers
- Trades disclosed
- 50
- Buys
- 18
- Sells
- 0
- Bought
- $1.0M
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 1
- First trade
- 28 Apr 2016
- Last trade
- 26 Jan 2026
- Last filed
- 27 Jan 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 26 Jan 2026filed 27 Jan 2026 | CRMD CorMedixPharmaceuticals | SEC FORM 4 Code A | —30,453 at $0.00 | filing |
| 26 Jan 2026filed 27 Jan 2026 | CRMD CorMedixPharmaceuticals | SEC FORM 4 Code A | —30,453 at $0.00 | filing |
| 23 Oct 2025filed 27 Oct 2025 | CRMD CorMedixPharmaceuticals | SEC FORM 4 Bought | $276K25,000 at $11.02 | filing |
| 17 Jan 2025filed 22 Jan 2025 | CRMD CorMedixPharmaceuticals | SEC FORM 4 Code A | —25,000 at $0.00 | filing |
| 5 Mar 2024filed 20 Mar 2024 | CRMD CorMedixoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —30,000 at $0.00 | filing |
| 18 May 2023filed 19 May 2023 | CRMD CorMedixPharmaceuticals | SEC FORM 4 Bought | $27K6,000 at $4.54 | filing |
| 14 Jan 2023filed 18 Jan 2023 | CRMD CorMedixoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —20,000 at $0.00 | filing |
| 17 May 2022filed 18 May 2022 | CRMD CorMedixPharmaceuticals | SEC FORM 4 Bought | $19K5,000 at $3.78 | filing |
| 22 Feb 2022filed 23 Feb 2022 | CRMD CorMedixoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —20,000 at $0.00 | filing |
| 27 Dec 2021filed 29 Dec 2021 | CRMD CorMedixPharmaceuticals | SEC FORM 4 Code G | —20,000 at $0.00 | filing |
| 27 Dec 2021filed 29 Dec 2021 | CRMD CorMedixPharmaceuticals | SEC FORM 4 Code G | —5,000 at $0.00 | filing |
| 27 Dec 2021filed 29 Dec 2021 | CRMD CorMedixPharmaceuticals | SEC FORM 4 Code G | —5,000 at $0.00 | filing |
| 27 Dec 2021filed 29 Dec 2021 | CRMD CorMedixPharmaceuticals | SEC FORM 4 Code G | —5,000 at $0.00 | filing |
| 16 Nov 2021filed 19 Nov 2021 | CRMD CorMedixPharmaceuticals | SEC FORM 4 Bought | $51K10,000 at $5.14 | filing |
| 17 May 2021filed 19 May 2021 | CRMD CorMedixPharmaceuticals | SEC FORM 4 Bought | $90K15,000 at $6.03 | filing |
| 11 Jan 2021filed 13 Jan 2021 | CRMD CorMedixoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —30,000 at $0.00 | filing |
| 2 Sep 2020filed 4 Sep 2020 | CRMD CorMedixPharmaceuticals | SEC FORM 4 Bought | $65K15,300 at $4.27 | filing |
| 13 Aug 2020filed 17 Aug 2020 | CRMD CorMedixPharmaceuticals | SEC FORM 4 Bought | $61K15,000 at $4.08 | filing |
| 15 May 2020filed 18 May 2020 | CRMD CorMedixPharmaceuticals | SEC FORM 4 Bought | $39K10,000 at $3.85 | filing |
| 25 Feb 2020filed 27 Feb 2020 | CRMD CorMedixoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | $84K15,000 at $5.63 | filing |
News
Contrasting CorMedix (NASDAQ:CRMD) & InMed Pharmaceuticals (NASDAQ:INM)CRMD · themarketsdaily.com · 22 Oct 2026Head-To-Head Survey: Inhibikase Therapeutics (NASDAQ:IKT) versus CorMedix (NASDAQ:CRMD)CRMD · themarketsdaily.com · 10 Oct 2026
0 headlines in the last 90 days name Myron Kaplan; 2 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.